A detailed history of Nisa Investment Advisors, LLC transactions in Macrogenics Inc stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 6,120 shares of MGNX stock, worth $19,951. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,120
Previous 6,261 2.25%
Holding current value
$19,951
Previous $26,000 23.08%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$3.0 - $5.55 $423 - $782
-141 Reduced 2.25%
6,120 $20,000
Q2 2024

Jul 19, 2024

BUY
$3.31 - $18.51 $76 - $425
23 Added 0.37%
6,261 $26,000
Q1 2024

May 01, 2024

BUY
$9.77 - $21.47 $566 - $1,245
58 Added 0.94%
6,238 $91,000
Q3 2023

Nov 02, 2023

BUY
$4.48 - $6.19 $44 - $61
10 Added 0.16%
6,180 $28,000
Q2 2023

Aug 11, 2023

BUY
$4.62 - $7.54 $4,620 - $7,540
1,000 Added 19.34%
6,170 $33,000
Q1 2023

May 02, 2023

SELL
$4.82 - $7.24 $139 - $209
-29 Reduced 0.56%
5,170 $37,000
Q4 2022

Feb 02, 2023

BUY
$3.34 - $6.98 $163 - $342
49 Added 0.95%
5,199 $35,000
Q3 2022

Nov 07, 2022

BUY
$3.01 - $5.22 $13,544 - $23,490
4,500 Added 692.31%
5,150 $26,000
Q1 2022

Apr 29, 2022

SELL
$8.12 - $16.9 $44,083 - $91,750
-5,429 Reduced 89.31%
650 $6,000
Q4 2021

Feb 03, 2022

BUY
$15.91 - $21.88 $30,690 - $42,206
1,929 Added 46.48%
6,079 $75,000
Q1 2021

Apr 26, 2021

BUY
$18.99 - $33.2 $55,070 - $96,280
2,900 Added 232.0%
4,150 $132,000
Q4 2020

Jan 25, 2021

SELL
$19.41 - $26.0 $17,469 - $23,400
-900 Reduced 41.86%
1,250 $29,000
Q3 2020

Oct 20, 2020

BUY
$24.69 - $31.6 $38,269 - $48,980
1,550 Added 258.33%
2,150 $54,000
Q2 2020

Jul 27, 2020

SELL
$5.2 - $29.12 $520 - $2,912
-100 Reduced 14.29%
600 $17,000
Q1 2020

Apr 17, 2020

BUY
$4.28 - $12.11 $2,996 - $8,477
700 New
700 $4,000
Q4 2019

Jan 17, 2020

SELL
$7.95 - $12.27 $1,590 - $2,454
-200 Closed
0 $0
Q3 2019

Oct 17, 2019

BUY
$12.44 - $17.48 $2,488 - $3,496
200 New
200 $3,000

Others Institutions Holding MGNX

About MACROGENICS INC


  • Ticker MGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,458,800
  • Market Cap $200M
  • Description
  • MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...
More about MGNX
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.